Bavarian Nordic
Stock
Stock
ISIN: DK0015998017
Ticker: BAVA
DK0015998017
BAVA
Price
Price
CHART BY
Frequently asked questions
What is Bavarian Nordic's market capitalization?
The market capitalization of Bavarian Nordic is $2.39B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Bavarian Nordic's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Bavarian Nordic is 10.19. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Bavarian Nordic?
Bavarian Nordic's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $3.087. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Bavarian Nordic's stock?
Currently, 7 analysts cover Bavarian Nordic's stock, with a consensus target price of $43.09. Analyst ratings provide insights into the stock's expected performance.
What is Bavarian Nordic's revenue over the trailing twelve months?
Over the trailing twelve months, Bavarian Nordic reported a revenue of $965.72M.
What is the EBITDA for Bavarian Nordic?
Bavarian Nordic's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $270.91M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Bavarian Nordic?
Bavarian Nordic has a free cash flow of $191.21M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Bavarian Nordic have, and what sector and industry does it belong to?
Bavarian Nordic employs approximately 1,795 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Bavarian Nordic's shares?
The free float of Bavarian Nordic is 64.56M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.39B
- EPS (TTM)
- $3.087
- Free Float
- 64.56M
- P/E ratio (TTM)
- 10.19
- Revenue (TTM)
- $965.72M
- EBITDA (TTM)
- $270.91M
- Free Cashflow (TTM)
- $191.21M
Pricing
- 1D span
- $31.34$31.69
- 52W span
- $26.19$37.90
Analyst Ratings
The price target is $43.09 and the stock is covered by 7 analysts.
Buy
7
Hold
0
Sell
0
Information
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
- Employees
- 1,795
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- DK0015998017
- Primary Ticker
- BAVA
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet